Brien Ragle

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

BNG America provides US clean-up and remediation services. The company delivers technical solutions to two principal markets. In the public sector, the company support the US Department of Energy with its nuclear clean-up programme - the largest funded in the world. In the private sector, It is decommissioning nuclear reactors owned by US utility companies. The company provide decommissioning services, technology development, nuclear facility maintenance and waste management - generating interchangeable skills that benefit the whole of British Nuclear Group. Founded in 1990, the company operates several subsidiaries, including Manufacturing Sciences Corporation (cast and roll depleted uranium) and BNG Fuel Solutions (spent fuel management services)